The diabetes therapeutic biguanides metformin and its more potent analog, phenformin, inhibit mitochondrial respiratory chain complex I and ATP synthesis, thus resulting in energy stress and indirectly activating AMPK [40,41,42]. This evidence concerns the gene PRKAA2 and diabetes mellitus.